» Authors » Omar P Vallejos

Omar P Vallejos

Explore the profile of Omar P Vallejos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 332
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vallejos O, Bueno S, Kalergis A
Trends Mol Med . 2025 Jan; PMID: 39814640
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder that represents a significant public health challenge worldwide. This multifactorial condition results from complex interactions among genetic, environmental, immune, and microbial...
2.
Sepulveda-Alfaro J, Catalan E, Vallejos O, Ramos-Tapia I, Madrid-Munoz C, Mendoza-Leon M, et al.
Front Immunol . 2024 Feb; 15:1330209. PMID: 38404579
Introduction: Respiratory infections are one of the leading causes of morbidity and mortality worldwide, mainly in children, immunocompromised people, and the elderly. Several respiratory viruses can induce intestinal inflammation and...
3.
Hoppe-Elsholz G, Pina-Iturbe A, Vallejos O, Suazo I, Sepulveda-Alfaro J, Pereira-Sanchez P, et al.
Front Microbiol . 2023 Nov; 14:1236458. PMID: 38029095
Excisable genomic islands (EGIs) are horizontally acquired genetic elements that harbor an array of genes with diverse functions. ROD21 is an EGI found integrated in the chromosome of serovar Enteritidis...
4.
Mendoza-Leon M, Mangalam A, Regaldiz A, Gonzalez-Madrid E, Rangel-Ramirez M, Alvarez-Mardonez O, et al.
Front Endocrinol (Lausanne) . 2023 Jul; 14:1192216. PMID: 37455925
Thyroid disorders are clinically characterized by alterations of L-3,5,3',5'-tetraiodothyronine (T), L-3,5,3'-triiodothyronine (T), and/or thyroid-stimulating hormone (TSH) levels in the blood. The most frequent thyroid disorders are hypothyroidism, hyperthyroidism, and hypothyroxinemia....
5.
Galvez N, Pacheco G, Schultz B, Melo-Gonzalez F, Soto J, Duarte L, et al.
Elife . 2022 Oct; 11. PMID: 36226829
Background: The development of vaccines to control the coronavirus disease 2019 (COVID-19) pandemic progression is a worldwide priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine...
6.
Schultz B, Melo-Gonzalez F, Duarte L, Galvez N, Pacheco G, Soto J, et al.
mBio . 2022 Aug; 13(4):e0142322. PMID: 35946814
CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization (WHO). Previous studies reported increased levels of neutralizing antibodies and specific T cells 2 and 4 weeks after...
7.
Sebastian V, Moreno-Tapia D, Melo-Gonzalez F, Hernandez-Caceres M, Salazar G, Pardo-Roa C, et al.
Antioxidants (Basel) . 2022 Jun; 11(6). PMID: 35739937
An important virulence trait of serovar Typhimurium ( Typhimurium) is the ability to avoid the host immune response, generating systemic and persistent infections. Host cells play a crucial role in...
8.
Schultz B, Melo-Gonzalez F, Duarte L, Galvez N, Pacheco G, Soto J, et al.
medRxiv . 2022 Apr; PMID: 35441179
Background: CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization. Previous studies reported increased levels of neutralizing antibodies and specific T cells two- and four-weeks after two...
9.
Bueno S, Abarca K, Gonzalez P, Galvez N, Soto J, Duarte L, et al.
medRxiv . 2022 Apr; PMID: 35441164
Background: The ongoing COVID-19 pandemic has had a significant impact worldwide, with an incommensurable social and economic burden. The rapid development of safe and protective vaccines against this disease is...
10.
Melo-Gonzalez F, Soto J, Gonzalez L, Fernandez J, Duarte L, Schultz B, et al.
Front Immunol . 2021 Dec; 12:747830. PMID: 34858404
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, several circulating variants have...